+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Muscarinic cholinergic agonists increase beta adrenergic receptor affinity for catecholamines and inhibit catecholamine stimulation of adenylate cyclase



Muscarinic cholinergic agonists increase beta adrenergic receptor affinity for catecholamines and inhibit catecholamine stimulation of adenylate cyclase



Journal of Supramolecular Structure 7(Suppl. 2): 146




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 027002672

Download citation: RISBibTeXText


Related references

Muscarinic cholinergic receptor modulation of beta adrenergic receptor affinity for catecholamines and catecholamine stimulation of adenylate cyclase activity. Clinical Research 26(3): 486A, 1978

Muscarinic cholinergic agonists regulate beta adrenergic receptor and adenylate cyclase in ventricular myo cardium. Federation Proceedings 37(6): 1788, 1978

Effects of muscarinic cholinergic receptor agonists on beta adrenergic and histamine h 2 receptor stimulated adenylate cyclase activity in guinea pig myo cardium. Clinical Research 30(4): 816A, 1982

A high affinity agonist beta adrenergic receptor complex is an intermediate for catecholamine stimulation of adenylate cyclase in turkey and frog erythrocyte membranes. Journal of Biological Chemistry 255(4): 1436-1441, 1980

Muscarinic receptor agonists inhibit cardiac adenylate cyclase activity in the presence of gdp beta s or gdp. FASEB Journal 4(7): A1985, 1990

Beta-Adrenergic receptor agonists increase phospholipid methylation, membrane fluidity, and beta-adrenergic receptor-adenylate cyclase coupling. Proceedings of the National Academy of Sciences of the United States of America 76(1): 368-372, 1979

Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines. Journal of Biological Chemistry 253(14): 4833-4836, 1978

Concanavalin A amplifies both beta-adrenergic and muscarinic cholinergic receptor-adenylate cyclase-linked pathways in cardiac myocytes. Journal of Clinical Investigation 88(3): 760-766, 1991

Autonomic interactions in the aging heart: age-associated decrease in muscarinic cholinergic receptor mediated inhibition of beta-adrenergic activation of adenylate cyclase. Mechanisms of Ageing and Development 34(3): 249-259, 1986

Beta-Adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. Journal of Biological Chemistry 263(8): 3893-3897, 1988

Adenylate cyclase coupled beta adrenergic receptors effect of membrane lipid perturbing agents on receptor binding and enzyme stimulation by catecholamines. Molecular Pharmacology 12(4): 559-567, 1976

Regulation of adenylate cyclase coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro. Molecular Pharmacology 12(3): 409-419, 1976

Ace-associated decline in muscarinic cholinergic receptor (MChR) mediated inhibition of cardiac β-adrenergic receptor linked adenylate cyclase (AC). Journal of Molecular and Cellular Cardiology 18(Supp-S3): 51-51, 1986

Muscarinic receptor agonists inhibit adenylate cyclase of membranes from rat cerebellar granule cells in primary culture. Federation Proceedings 45(3): 661, 1986

Structure-activity relationships of beta-adrenergic receptor-coupled adenylate cyclase: implications of a redox mechanism for the action of agonists at beta-adrenergic receptors. Molecular Pharmacology 31(4): 368-376, 1987